1. Home
  2. What We do
  3. JMACCT Clinical Trial Registry

What We do

JMACCT Clinical Trial Registry

Clinical Trials List

CTR official site

※Detailed information is displayed when you click on the title.

1 Open-Label Trial to Evaluate the Efficacy and Safety of the Use of Argatroban in Patients With Heparin-Induced Thrombocytopenia
JMACCT ID JMA-IIA00001
Date JMACCT ID assigned 21-Dec-05
Investigator name Haruko Yamamoto
2 A phase III, efficacy and safety study of phenobarbital sodium injection in newborns with neonatal convulsion
JMACCT ID JMA-IIA00002
Date JMACCT ID assigned 4-Jan-06
Investigator name Susumu Itoh
3 Phase2 Study of Glivec (imatinib mesylate, formerly known as STI571) in Patients with Relapsed or Refractory Sarcomas with c-kit or PDGFR Expression
JMACCT ID JMA-IIA00003
Date JMACCT ID assigned 28-Dec-05
Investigator name Yasuhiro Fujiwara, MD, PhD
4 Phase I-II clinical trial of irinotecan hydrochloride (CPT-11) for refractory pediatric solid tumors
JMACCT ID JMA-IIA00004
Date JMACCT ID assigned 27-Jan-06
Investigator name Atsushi Makimoto
5 J-BAF study Evaluation of the efficacy and safety of Bepridil hydrochloride in the conversion of persistent atrial fibrillation.A placebo-controlled, randomized, double-blind study.
JMACCT ID JMA-IIA00005
Date JMACCT ID assigned 15-Feb-06
Investigator name Satoshi Ogawa, M.D., Ph.D
6 evaluation of safety, dosage and efficacy of fentanyl in neonates and children of age 6 years old and younger -uncontrolled, open label study-
JMACCT ID JMA-IIA00006
Date JMACCT ID assigned 8-Mar-06
Investigator name Hidefumi Nakamura, M.D.,Ph.D. Director
7 A Phase II/III, Confirmatory, Randomized, Double-Blind, Parallel-Group Study to Assess the Safety and Immunogenicity of Intramuscular KIB-PIA (H5N1 influenza vaccine) in Healthy Adult Japanese Volunteers
JMACCT ID JMA-IIA00007
Date JMACCT ID assigned 9-Aug-06
Investigator name Hitoshi Kamiya
8 Double-blind Placebo-controlled Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)
JMACCT ID JMA-IIA00008
Date JMACCT ID assigned 9-Aug-06
Investigator name Hitoshi Kamiya
9 A Phase II/III, Confirmatory, Randomized, Double-Blind, Parallel-Group Study to Assess the Safety and Immunogenicity of Subcutaneous BK-PIFA (H5N1 influenza vaccine) in Healthy Adult Japanese Volunteers
JMACCT ID JMA-IIA00009
Date JMACCT ID assigned 24-Aug-06
Investigator name Gen Sobue
10 Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)
JMACCT ID JMA-IIA00010
Date JMACCT ID assigned 11-May-07
Investigator name Atushi Ohtsu, MD, PhD
11 Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial)
JMACCT ID JMA-IIA00011
Date JMACCT ID assigned 29-Jun-07
Investigator name Frank McCormack, M.D.
12 An open-label clinical trial of the combination treatment of tacrolimus and corticosteroid in polymyositis/dermatomyositis patients with interstitial pneumonitis, with comparison against corticosteroid-treated historical controls
JMACCT ID JMA-IIA00012
Date JMACCT ID assigned 5-Jul-07
Investigator name Nobuyuki Miyasaka
13 A Phase II Study of Inhaled GM-CSF in Patients With Idiopathic Pulmonary Alveolar Proteinosis (iPAP)
JMACCT ID JMA-IIA00013
Date JMACCT ID assigned 16-Aug-07
Investigator name Koh Nakata, M.D., Ph.D.
14 Clinical evaluation of stiripentol in Dravet syndrome
JMACCT ID JMA-IIA00014
Date JMACCT ID assigned 6-Nov-07
Investigator name Yushi Inoue
15 A Phase II, Open, Randomized Study to Assess the Safety and Immunogenicity of Intramuscular KIB-PIA(H5N1 influenza vaccine) in Healthy Children
JMACCT ID JMA-IIA00015
Date JMACCT ID assigned 14-Apr-08
Investigator name Hitoshi Kamiya
16 A Phase II, Open, Randomized Study to Assess the Safety and Immunogenicity of Intramuscular BK-PIFA (H5N1 influenza vaccine) in Healthy Children
JMACCT ID JMA-IIA00016
Date JMACCT ID assigned 14-Apr-08
Investigator name Hitoshi Kamiya
17 Phase IV, Open-label Study to Assess the Durability and Cross-immunity of H5N1 influenza vaccine in Healthy Adult Japanese Volunteers
JMACCT ID JMA-IIA00017
Date JMACCT ID assigned 31-Jul-08
Investigator name Toshiaki Ihara
18 Phase IV, Open-label Study to Assess the Booster Effect of H5N1 Influenza Vaccine in Healthy Adult Japanese Volunteers
JMACCT ID JMA-IIA00018
Date JMACCT ID assigned 31-Jul-08
Investigator name Toshiaki Ihara
19 Phase IV, Open-label Study to Assess the Safety of H5N1 Pre-pandemic Vaccine (BK-KIB-01)
JMACCT ID JMA-IIA00019
Date JMACCT ID assigned 31-Jul-08
Investigator name Suminobu Ito
20 Double-Blind Study of IDEC-C2B8 in Patients with Childhood-onset Refractory Nephrotic Syndrome
JMACCT ID JMA-IIA00020
Date JMACCT ID assigned 19-Sep-08
Investigator name Kazumoto Iijima

Page Top